Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design

Mao Shuai; Wang Lei; Zhao Xujie; Shang Hongcai; Zhang Minzhou; Hinek Aleksander

首页> 外文期刊>International Journal of Cardiology >Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design

【24h】

Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design

机译：丹参酮IIA磺酸钠用于减少经皮冠状动脉介入治疗过程中的围手术期心肌损伤（STAMP试验）：原理和设计

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Cardiology》 |2015年第null期|共5页
作者
Mao Shuai; Wang Lei; Zhao Xujie; Shang Hongcai; Zhang Minzhou; Hinek Aleksander;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Sodium tanshinone IIA sulfonate; Periprocedural myocardial infarction; Non-ST-segment elevation acute; coronary syndrome; Percutaneous coronary intervention;

机译：丹参酮ⅡA磺酸钠;术前心肌梗死;非ST段抬高急性;冠状动脉综合征;经皮冠状动脉介入治疗;

相似文献

外文文献
中文文献
专利

1. Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design [J] . Mao Shuai, Wang Lei, Zhao Xujie, International Journal of Cardiology . 2015,第Null期

机译：丹参酮IIA磺酸钠用于减少经皮冠状动脉介入治疗过程中的围手术期心肌损伤（STAMP试验）：原理和设计
2. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial [J] . Mao Shuai, Wang Lei, Zhao Xujie, Cardiovascular drugs and therapy . 2021,第2期

机译：丹参酮IIA磺酸钠在经皮冠状动脉干预中的非St升高急性冠状动脉综合征患者中的疗效：多期，受控，随机试验的结果
3. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention [J] . Aslanabadi Naser, Shirzadi Hamid Reza, Asghari-Soufi Hossein, European journal of clinical pharmacology . 2015,第2期

机译：己酮可可碱在接受选择性经皮冠状动脉介入治疗的患者中减少围手术期心肌损伤的随机试验
4. Preparation, Characterization evaluation of Tanshinone IIA lipid microspere and comparative study of pharmacokinetics with Sodium Tanshinone IIA Sulfonate injection [C] . Xinli Liang, Mengliang Zhu, Yunchao Cao International Conference on Chemical Engineering and Advanced Materials . 2013

机译：丹参酮脂质微孔的制备，表征评价及药代动力学对丹参酮IIA磺酸钠注射液的比较研究
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Rationale and design of the OPTIMAL‐REPERFUSION trial: A prospective randomized multi‐center clinical trial comparing different fibrinolysis‐transfer percutaneous coronary intervention strategies in acute ST‐segment elevation myocardial infarction [O] . Zhongxiu Chen, Duolao Wang, Min Ma, 2021

机译：最佳再灌注试验的理由和设计：一项前瞻性随机化多中心临床试验比较不同纤维蛋白溶解转移经皮冠状动脉干预策略在急性ST段抬高心肌梗死中
7. Rationale and Design of a Large-Scale Trial Using Nicorandil as an Adjunct to Percutaneous Coronary Intervention for ST-Segment Elevation Acute Myocardial Infarction-Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP Channel Opener (J-WIND-KATP)- [O] . Tetsuo Minamino, Kim Jiyoong, Masanori Asakura, 2004

机译：使用Nicorandil作为经皮冠状动脉干预的急性心肌梗死 - 日本工作组的急性心肌梗死的辅助理由和设计急性心肌梗死的辅助冠状动脉梗死，用于通过K-ATP通道开启器减少坏死性损伤（J. -wind-katp） -

Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design

著录项

相似文献

相关主题

期刊订阅